Testing effectiveness (Phase 2)Ended earlyNCT01586195
What this trial is testing
Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E
Who this might be right for
Malignant Melanoma
Genentech, Inc. 31